Completed OBSERVATIONAL NCT00770198

sgp130 in Chronic Human Liver Disease

Study of IL-6 Transsignaling in Chronic Human Liver Disease

Sponsor: Erasme University Hospital

Conditions Alcoholic Liver Disease Chronic Hepatitis C Virus Infection

Updated 9 times since 2017 Last updated: Oct 8, 2008 Started: Jan 31, 2005 Primary completion: Jan 31, 2007 Completion: Oct 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00770198, this observational or N/A phase trial focuses on Alcoholic Liver Disease and Chronic Hepatitis C Virus Infection and remains completed. Sponsored by Erasme University Hospital, it has been updated 9 times since 2005, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 4 earlier versions

May 2018 — Nov 2020 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Aug 2017 [monthly]

Completed NA

First recorded

Jan 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Erasme University Hospital

Data source: Erasme University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brussels, Belgium